2022 Update on Clinical Management of Graves Disease and Thyroid Eye Disease

Thanh D. Hoang; Derek J. Stocker; Eva L. Chou; Henry B. Burch

doi:10.1016/j.ecl.2021.12.004

2022 Update on Clinical Management of Graves Disease and Thyroid Eye Disease

Thanh D. Hoang, Derek J. Stocker, Eva L. Chou, Henry B. Burch^*

^*Corresponding author for this work

Medicine

Research output: Contribution to journal › Article › peer-review

75 Scopus citations

Abstract

The management of hyperthyroidism and extrathyroidal manifestations of Graves disease remains complex. Considerations that include patient preference, age, comorbidity, pregnancy, tobacco smoking, and social determinants of health must all be weaved into a cohesive management plan. A multidisciplinary team is required to manage all aspects of Graves disease, particularly thyroid eye disease, for which new therapeutic options are now available.

Original language	English
Pages (from-to)	287-304
Number of pages	18
Journal	Endocrinology and Metabolism Clinics of North America
Volume	51
Issue number	2
DOIs	https://doi.org/10.1016/j.ecl.2021.12.004
State	Published - Jun 2022

Keywords

Antithyroid Agents/therapeutic use
Female
Graves Disease/drug therapy
Graves Ophthalmopathy/diagnosis
Humans
Iodine Radioisotopes/therapeutic use
Pregnancy
Thyroidectomy

Access to Document

10.1016/j.ecl.2021.12.004

Cite this

@article{7d7f5cbb829f4faf9025a50427b061f5,

title = "2022 Update on Clinical Management of Graves Disease and Thyroid Eye Disease",

abstract = "The management of hyperthyroidism and extrathyroidal manifestations of Graves disease remains complex. Considerations that include patient preference, age, comorbidity, pregnancy, tobacco smoking, and social determinants of health must all be weaved into a cohesive management plan. A multidisciplinary team is required to manage all aspects of Graves disease, particularly thyroid eye disease, for which new therapeutic options are now available.",

keywords = "Antithyroid Agents/therapeutic use, Female, Graves Disease/drug therapy, Graves Ophthalmopathy/diagnosis, Humans, Iodine Radioisotopes/therapeutic use, Pregnancy, Thyroidectomy",

author = "Hoang, {Thanh D.} and Stocker, {Derek J.} and Chou, {Eva L.} and Burch, {Henry B.}",

year = "2022",

month = jun,

doi = "10.1016/j.ecl.2021.12.004",

language = "English",

volume = "51",

pages = "287--304",

journal = "Endocrinology and Metabolism Clinics of North America",

issn = "0889-8529",

publisher = "W.B. Saunders",

number = "2",

}

TY - JOUR

T1 - 2022 Update on Clinical Management of Graves Disease and Thyroid Eye Disease

AU - Hoang, Thanh D.

AU - Stocker, Derek J.

AU - Chou, Eva L.

AU - Burch, Henry B.

PY - 2022/6

Y1 - 2022/6

N2 - The management of hyperthyroidism and extrathyroidal manifestations of Graves disease remains complex. Considerations that include patient preference, age, comorbidity, pregnancy, tobacco smoking, and social determinants of health must all be weaved into a cohesive management plan. A multidisciplinary team is required to manage all aspects of Graves disease, particularly thyroid eye disease, for which new therapeutic options are now available.

AB - The management of hyperthyroidism and extrathyroidal manifestations of Graves disease remains complex. Considerations that include patient preference, age, comorbidity, pregnancy, tobacco smoking, and social determinants of health must all be weaved into a cohesive management plan. A multidisciplinary team is required to manage all aspects of Graves disease, particularly thyroid eye disease, for which new therapeutic options are now available.

KW - Antithyroid Agents/therapeutic use

KW - Female

KW - Graves Disease/drug therapy

KW - Graves Ophthalmopathy/diagnosis

KW - Humans

KW - Iodine Radioisotopes/therapeutic use

KW - Pregnancy

KW - Thyroidectomy

UR - http://www.scopus.com/inward/record.url?scp=85130310124&partnerID=8YFLogxK

U2 - 10.1016/j.ecl.2021.12.004

DO - 10.1016/j.ecl.2021.12.004

M3 - Article

C2 - 35662442

AN - SCOPUS:85130310124

SN - 0889-8529

VL - 51

SP - 287

EP - 304

JO - Endocrinology and Metabolism Clinics of North America

JF - Endocrinology and Metabolism Clinics of North America

IS - 2

ER -

2022 Update on Clinical Management of Graves Disease and Thyroid Eye Disease

Abstract

Keywords

Access to Document

Fingerprint

Cite this